Positive predictive values of selected hospital discharge diagnoses to identify infections responsible for hospitalization in the French national hospital database

Abstract

Hospitalizations for infection codes have very good PPVs in the Programme de Médicalisation des Systèmes d'Informations. Copyright © 2016 John Wiley & Sons, Ltd.

Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study

“…Using nationwide register-based data on the entire French population provided a large sample size, allowing for sufficient power to perform comprehensive and multiple subgroups analyses on the risk of acute arterial events. Additionally, several studies have found the reliability, validity and accuracy of medical coding in the French administrative database for various diseases to be good 38–42. The identification of acute arterial events in the present study was similar to that in a previous study, based on the same inpatient database, reporting an increased risk of acute arterial events in patients with IBD compared with the general population 2…”

Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases

“…32 Although identification of infection was based on discharge diagnosis only, the validity of our outcomes was recently assessed, with more than 95% accuracy of recorded cases and type of infections. 23 In addition, incidence rates of serious infections in patients exposed to anti-TNFs reported in our study are similar to those reported in the TREAT registry. The increased risk associated with thiopurines or anti-TNFs compared with unexposed patients reported in our study may also strengthen the external validity of our findings.…”

“…Within this database, the diagnoses of infection requiring hospitalization and the type of infection have been shown to be accurate in 97% and 98% of the cases, respectively. 23 Serious infections were classified according to infection sites. These included pulmonary; gastrointestinal; skin; urinary tract; ear, nose and throat; musculoskeletal; and other infections (including sepsis, nonclassified opportunistic, and mycobacterial infections).…”

Therapeutic management of inflammatory bowel disease in real‐life practice in the current era of anti‐TNF agents: analysis of the French administrative health databases 2009–2014

“…Excluded health insurance schemes relate to specific professions and do not depend on comorbidities or medical conditions. Several studies have assessed the reliability of the recorded information and the accuracy of its coding in different fields . Moreover, the PMSI and SNIIRAM have been used to measure disease incidence and identify determinants of medical conditions in various fields …”